Royalty Gets 68K Shares Of Support For $6.3B Elan Takeover
Royalty Pharma AG said Friday that stakeholders in U.K. drugmaker Elan Corp., who hold roughly 68,000 combined shares, had agreed to vote in favor of the New York investor's $6.3 billion...To view the full article, register now.
Already a subscriber? Click here to view full article